Accumulating data demonstrated that CXCL13 and LTα1β2 might be the “bio-marker” predicting the formation of TLOs in some diseases, such as RA, SS, and atherosclerosis (87, 88). The gene discussed is CXCL13; the disease is rheumatoid arthritis.